ParkerVision reports 2023 net income of $9.5M vs loss of $9.8M in 2022; patent trial dates set

PARKERVISION INC

Net income $9.5M (EPS $0.11 basic, $0.08 diluted) vs net loss $9.8M in 2022.
Revenue increased $24.1M from patent licensing and enforcement, including a $25M settlement in 2023.
Repaid $13.9M on secured contingent debt; borrowed $5M at lower rate; extended $1.2M convertible debt maturities by 2+ years.
Jury trials scheduled: MediaTek Dec 2024, Realtek Jan 2025; CAFC appeal on Qualcomm case pending.
Cash $2.6M at Dec 31, 2023; accounts payable reduced 36%.

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

PARKERVISION INC reported the year ended December 31, 2023 results: revenue $24.1 million increase in revenue, net income $9.5 million, EPS $0.11 and $0.08 respectively for 2023.

Period: the year ended December 31, 2023
Revenue: $24.1 million increase in revenue
Net income: $9.5 million
EPS: $0.11 and $0.08 respectively for 2023
Result: reported results

Exact text from the filing

for 2023, compared to basic and diluted loss per common share of $(0.13) in 2022. o The $19.3 million increase in earnings from 2022 to 2023 is primarily the result of a $24.1 million increase in revenue resulting from our patent enforcement and licensing efforts, a $2.6 million decrease in the loss related to the change in fair value of our contingent payment

View on SEC.gov

Browse all earnings releases →

PARKERVISION INC filing history →

Source: SEC EDGAR

accession 0001437749-24-008857

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.